LungLife AI Inc has recorded no insider trading activity within the past three months. The most recent transactions occurred on August 14, 2023, when the Chief Executive Officer and Chief Financial Officer each purchased shares valued at 8,466.70. Historical data indicates consistent buying patterns from key leadership members over previous years.